Emerging transcatheter heart valve technologies for severe aortic stenosis

References

• Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014 May;56(6):565–571. doi: 10.1016/j.pcad.2014.02.006
   PubMed Web of Science ®Google Scholar
• Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The tromso study. Heart. 2013 Mar;99(6):396–400. doi: 10.1136/heartjnl-2012-302265
   PubMed Web of Science ®Google Scholar
• Gott VL, Alejo DE, Cameron DE. Mechanical heart valves: 50 years of evolution. Ann Thorac Surg. 2003 Dec;76(6):S2230–9. doi: 10.1016/j.athoracsur.2003.09.002
   PubMed Web of Science ®Google Scholar
• Cribier A, Saoudi N, Berland J, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;327(8472):63–67. doi: 10.1016/S0140-6736(86)90716-6
   Google Scholar
• Haibo Z, Xu M. Transcatheter treatment of aortic stenosis and regurgitation. Advances In Complex Valvular Disease: IntechOpen. 2020. doi: 10.5772/intechopen.92997
   Google Scholar
• Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89(2):642–650. doi: 10.1161/01.CIR.89.2.642
   PubMed Web of Science ®Google Scholar
• ANDERSEN HR, KNUDSEN LL, HASENKAM JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13(5):704–708. doi: 10.1093/oxfordjournals.eurheartj.a060238
   PubMed Web of Science ®Google Scholar
• Andersen HR. How transcatheter aortic valve implantation (TAVI) was born: the struggle for a new Invention. Front Cardiovasc Med. 2021;8:722693. doi: 10.3389/fcvm.2021.722693
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006–3008. doi: 10.1161/01.CIR.0000047200.36165.B8
   PubMed Web of Science ®Google Scholar
• Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005 Dec;66(4):465–469. doi: 10.1002/ccd.20544
   PubMed Web of Science ®Google Scholar
• Cribier A. Invention and uptake of TAVI over the first 20 years. Nat Rev Cardiol. 2022 Jul;19(7):427–428. doi: 10.1038/s41569-022-00721-w
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi: 10.1056/NEJMoa1008232
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017 2017 Sep 21;38(36):2739–2791. doi: 10.1093/eurheartj/ehx391
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014 2014 Jun 10;63(22):e57–185. doi: 10.1016/j.jacc.2014.02.536
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017 2017 Jul 11;70(2):252–289. doi: 10.1016/j.jacc.2017.03.011
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Heijmen RH, Van Mieghem NM, et al. Comparison of outcomes after transcatheter vs surgical aortic valve replacement among patients at intermediate operative risk with a history of coronary artery bypass graft surgery: a post Hoc analysis of the SURTAVI randomized clinical trial. JAMA Cardiol. 2019 Aug 1;4(8):810–814. doi: 10.1001/jamacardio.2019.1856
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017 Apr 6;376(14):1321–1331. doi: 10.1056/NEJMoa1700456
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016 Apr 28;374(17):1609–1620. doi: 10.1056/NEJMoa1514616
   PubMed Web of Science ®Google Scholar
• Sondergaard L, Popma JJ, Reardon MJ, et al. Comparison of a complete percutaneous versus surgical approach to aortic valve replacement and revascularization in patients at intermediate surgical risk: results from the randomized SURTAVI trial. Circulation. 2019 Sep 3;140(16):1296–1305. doi: 10.1161/CIRCULATIONAHA.118.039564
   PubMed Web of Science ®Google Scholar
• Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020 Feb 27;382(9):799–809. doi: 10.1056/NEJMoa1910555
   PubMed Web of Science ®Google Scholar
• Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial. Circulation. 2020 Dec 22;142(25):2431–2442. doi: 10.1161/CIRCULATIONAHA.120.051547
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1706–1715. doi: 10.1056/NEJMoa1816885
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695–1705. doi: 10.1056/NEJMoa1814052
   PubMed Web of Science ®Google Scholar
• Waksman R, Craig PE, Torguson R, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC: Cardiovasc Interv. 2020 May 11;13(9):1019–1027. doi: 10.1016/j.jcin.2020.02.008
   PubMed Web of Science ®Google Scholar
• Jorgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021 Aug 7;42(30):2912–2919. doi: 10.1093/eurheartj/ehab375
   PubMed Web of Science ®Google Scholar
• Lanz J, Kim W-K, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619–1628. doi: 10.1016/S0140-6736(19)32220-2
   PubMed Web of Science ®Google Scholar
• Dogosh AA, Adawi A, El Nasasra A, et al. Comparison of transcatheter aortic valve implantation devices in aortic stenosis: a network meta-analysis of 42,105 patients. J Clin Med. 2022 Sep 8;11(18):5299. doi: 10.3390/jcm11185299
   PubMed Web of Science ®Google Scholar
• Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2021 2021 Aug 28;62(1). doi: 10.1093/ejcts/ezac209.
   Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2020 2021 Feb 2;77(4):e25–e197. doi: 10.1016/j.jacc.2020.11.018
   PubMed Web of Science ®Google Scholar
• Schoechlin S, Hein M, Brennemann T, et al. 5-year outcomes after transcatheter aortic valve implantation: focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters. Catheter Cardiovasc Interv. 2022 Apr;99(5):1582–1589. doi: 10.1002/ccd.30083
   PubMed Web of Science ®Google Scholar
• Okuno T, Tomii D, Heg D, et al. Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation. EuroIntervention. 2022 May 15;18(1):33–42. doi: 10.4244/EIJ-D-21-00784
   PubMed Web of Science ®Google Scholar
• Sá MP, Jacquemyn X, Van den Eynde J, et al. Impact of prosthesis-patient mismatch after transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2022;16(3):298–310. doi: 10.1016/j.jcmg.2022.07.013
   PubMed Web of Science ®Google Scholar
• Leone PP, Regazzoli D, Pagnesi M, et al. Predictors and clinical Impact of prosthesis-patient mismatch after self-expandable TAVR in small annuli. JACC: Cardiovasc Interv. 2021 Jun 14;14(11):1218–1228. doi: 10.1016/j.jcin.2021.03.060
   PubMed Web of Science ®Google Scholar
• Leone PP, Fazzari F, Cannata F, et al. Clinical and technical challenges of prosthesis-patient mismatch after transcatheter aortic valve implantation. Front Cardiovasc Med. 2021;8:670457. doi: 10.3389/fcvm.2021.670457
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012 Aug 7;60(6):493–501. doi: 10.1016/j.jacc.2012.03.054
   PubMed Web of Science ®Google Scholar
• van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. 2018 Jun 1;39(21):2003–2013. doi: 10.1093/eurheartj/ehx785
   PubMed Web of Science ®Google Scholar
• Gaede L, Kim WK, Liebetrau C, et al. Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. 2018 Jan;107(1):60–69. doi: 10.1007/s00392-017-1158-2
   PubMed Web of Science ®Google Scholar
• Tang GHL, Amat-Santos IJ, De Backer O, et al. Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR: From the ALIGN-TAVR Consortium. JACC: Cardiovasc Interv. 2022 Aug 8;15(15):1497–1518. doi: 10.1016/j.jcin.2022.06.001
   PubMed Web of Science ®Google Scholar
• Piazza N, Martucci G, Spaziano M. Commissural or coronary alignment for TAVR? JACC Cardiovasc Interv. 2022;15(2):147–149. doi: 10.1016/j.jcin.2021.12.012
   PubMed Web of Science ®Google Scholar
• Fatima B, Mohananey D, Khan FW, et al. Durability Data for Bioprosthetic Surgical Aortic Valve: A Systematic Review. JAMA Cardiol. 2019 Jan 1;4(1):71–80. doi: 10.1001/jamacardio.2018.4045
   PubMed Web of Science ®Google Scholar
• Kovarovic B, Helbock R, Baylous K, et al. Visions of TAVR future: development and optimization of a second generation novel Polymeric TAVR. J Biomech Eng. 2022 Jun 1;144(6). doi: 10.1115/1.4054149
   PubMed Web of Science ®Google Scholar
• DelveInsight. Transcatheter aortic valve replacement/implantation - market insights, competitive landscape and market forecast-2027: delveInsight business research LLP. 2022. Available from: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
   Google Scholar
• Bavaria JE, Griffith B, Heimansohn DA, et al. Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with RESILIA tissue. Ann Thorac Surg. 2022;115(6):1429–1436. doi: 10.1016/j.athoracsur.2021.12.058
   PubMed Web of Science ®Google Scholar
• Vinod HT, editor . The SAPIEN X4 with resilia tissue: the value of dry leaflet technology. Chicago (IL) USA2022: TVT; 2022.
   Google Scholar
• Grube E, editor . TAVR: new valves. Miami-valve 2023. Miami (FL) USA: MiamiValves.org; 2023.
   Google Scholar
• Elkoumy A, Jose J, Gunasekaran S, et al. Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication. Int J Cardiol. 2023 Apr 5;382:68–75. doi: 10.1016/j.ijcard.2023.04.003
   PubMed Web of Science ®Google Scholar
• Sharma SK, Rao RS, Chopra M, et al. Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis. Future Cardiol. 2020;17(1):73–80. doi: 10.2217/fca-2020-0020
   PubMedGoogle Scholar
• Elkoumy A, Jose J, Terkelsen CJ, et al. One-year outcomes after Myval implantation in patients with bicuspid aortic valve stenosis—A multicentre real-world experience. J Clin Med. 2023;12(6):2398. doi: 10.3390/jcm12062398
   PubMed Web of Science ®Google Scholar
• Kodali SK, Sorajja P, Meduri CU, et al. Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR. EuroIntervention. 2023 May 19;19(4):e352–e362. doi: 10.4244/EIJ-D-23-00282
   PubMed Web of Science ®Google Scholar
• Bapat V. DurAVR™ Transcatheter Heart Valve: Designed for Lifetime Patient Management. Heart Lung & Circulation. 2022;31:31. doi: 10.1016/j.hlc.2022.06.579
   Google Scholar
• Meduri C. DurAVR™ transcatheter aortic valve first-in-human study: impact of novel leaflet design. Late-breaking trials and Innovations. London: PCR London Valves; 2022.
   Google Scholar
• Gaia DF, Braz AM, Simonato M, et al. Mitral implant of the Inovare transcatheter heart valve in failed surgical bioprostheses: a novel alternative for valve-in-valve procedures. Interact Cardiovasc Thorac Surg. 2017 Apr 1;24(4):514–520. doi: 10.1093/icvts/ivw368
   PubMed Web of Science ®Google Scholar
• Panagides V, Mesnier J, Nuche J, et al. From the Evolut Pro to the Evolut FX self-expanding transcatheter aortic valve replacement systems: current status and future perspectives. Expert Rev Med Devices. 2022 2022 Jul 3;19(7):561–569. doi: 10.1080/17434440.2022.2113386
   PubMed Web of Science ®Google Scholar
• Tarantini G, Tang G, Nai Fovino L, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European association of percutaneous cardiovascular interventions in collaboration with the ESC working group on cardiovascular surgery. EuroIntervention. 2023 Feb 22; 19: 37–52. doi: 10.4244/EIJ-D-22-00958
   PubMed Web of Science ®Google Scholar
• Wang X, De Backer O, Bieliauskas G, et al. Cusp symmetry and coronary ostial eccentricity and its Impact on coronary access following TAVR. JACC Cardiovasc Interv. 2022;15(2):123–134. doi: 10.1016/j.jcin.2021.11.010
   PubMed Web of Science ®Google Scholar
• Khera S, Krishnamoorthy P, Sharma SK, et al. Improved commissural alignment in TAVR with the newest Evolut FX self-expanding supra-annular valve: first-in-human experience. JACC: Cardiovasc Interv. 2023 Feb 27;16(4):498–500. doi: 10.1016/j.jcin.2022.10.041
   PubMed Web of Science ®Google Scholar
• Kroon HG, van Gils L, Ziviello F, et al. Impact of baseline and newly acquired conduction disorders on need for permanent pacemakers with 3 consecutive generations of self-expanding transcatheter aortic heart valves. Cardiovasc Revasc Med. 2022 Jan;34:40–45.
   PubMed Web of Science ®Google Scholar
• Pellegrini C, Garot P, Morice MC, et al. Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis. EuroIntervention. 2022 Sep 21;18(13):e1077–e1087. doi: 10.4244/EIJ-D-22-00558
   PubMed Web of Science ®Google Scholar
• Baggio S, Pagnesi M, Kim WK, et al. Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. EuroIntervention. 2022 Sep 12;18(12):977–986. doi: 10.4244/EIJ-D-22-00498
   PubMed Web of Science ®Google Scholar
• Santos-Martinez S, Halim J, Castro-Mejia A, et al. Myval versus alternative balloon- and self-expandable transcatheter heart valves: a central core lab analysis of conduction disturbances. Int J Cardiol. 2022 Jan 1;351:25–31. doi: 10.1016/j.ijcard.2021.12.049
   PubMed Web of Science ®Google Scholar
• Grubb KJ, Gada H, Mittal S, et al. Clinical Impact of standardized TAVR technique and care pathway: insights from the optimize PRO study. JACC: Cardiovasc Interv. 2023 Mar 13;16(5):558–570. doi: 10.1016/j.jcin.2023.01.016
   PubMed Web of Science ®Google Scholar
• BostonScientific. Acurate ide trial/prime-xl nested registry: BostonScientific. 2022 Available from: https://www.bostonscientific.com/en-US/medical-specialties/structural-heart/acurate-ide-trial/prime-xl-nested-registry-for-physicians.html
   Google Scholar
• Bajoras V, Nuyens P, Vanhaverbeke M, et al. TAVR with the novel Navitor Titan™ transcatheter heart valve to treat aortic stenosis patients with large aortic annuli. Cardiovasc Revasc Med. 2022 Apr 2;40:120–122. doi: 10.1016/j.carrev.2022.03.028
   PubMed Web of Science ®Google Scholar
• Abbott. Navitor TitanTM transcatheter aortic valve implantation system 2022. Available from: https://manuals.plus/abbott/navitor-titan-transcatheter-aortic-valve-implantation-system-manual#ixzz7wgLh3kyD
   Google Scholar
• Wang M, Song G, Chen M, et al. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention. 2022 Jan 28;17(13):1070–1076. doi: 10.4244/EIJ-D-21-00040
   PubMed Web of Science ®Google Scholar
• Kasparas BV, Rumbinaite E, Jurenas M, et al. Early safety and performance of the Vienna TAVI system: first-in-human feasibility study results (VIVA trial). TAVI: Late-Breaking Trials and Innovations. PCR London Valves; 2022.
   Google Scholar
• Liu Q, Mei J, Zhang H, et al. A study of the novel SinoCrown system for transcatheter aortic valve implantation. EuroIntervention. 2023 Jan 16;18(17):1439–1441. doi: 10.4244/EIJ-D-22-00090
   PubMed Web of Science ®Google Scholar
• Wenaweser P, Stortecky S, Schutz T, et al. Transcatheter aortic valve implantation with the NVT allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve. EuroIntervention. 2016 May 17;12(1):71–77. doi: 10.4244/EIJV12I1A13
   PubMed Web of Science ®Google Scholar
• BioWsensors (New Valve Technology N, Morges, Switzerland). ALLEGRA™ TAVI System. 2023 [cited 2023 Apr 6]. Available from: https://www.nvt-med.com/cardiac-valve-bioprothesis-aortic-valve.html
   Google Scholar
• Chandra P, Jose J, Mattummal S, et al. Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial. Catheter Cardiovasc Interv. 2021 Aug 1;98(2):371–379. doi: 10.1002/ccd.29733
   PubMed Web of Science ®Google Scholar
• Aidietis A, Srimahachota S, Dabrowski M, et al. 30-day and 1-year outcomes with HYDRA self-expanding transcatheter aortic valve: the Hydra CE study. JACC: Cardiovasc Interv. 2022 Jan 10;15(1):93–104. doi: 10.1016/j.jcin.2021.09.004
   PubMed Web of Science ®Google Scholar
• Leone PP, Scotti A, Ho EC, et al. Prosthesis tailoring for patients undergoing transcatheter aortic valve implantation. J Clin Med. 2023 Jan 1;12(1):338. doi: 10.3390/jcm12010338
   PubMed Web of Science ®Google Scholar
• Zhou D, Pan W, Wang J, et al. VitaFlow transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study. Catheter Cardiovasc Interv. 2020 Feb;95(2):332–338. doi: 10.1002/ccd.28226
   PubMed Web of Science ®Google Scholar
• Figulla HR, Ferrari M, Carr-Brendel V, et al. The JenaValve Program for Transcatheter Aortic Valve Implantation. In: Giordano A, Biondi-Zoccai G, Frati G, editors. Transcatheter Aortic Valve Implantation: Clinical, Interventional and Surgical Perspectives. Cham: Springer; 2019. p. 279–286. doi: 10.1007/978-3-030-05912-5_23
   Google Scholar
• Ng VG, Khalique OK, Nazif T, et al. Treatment of acute aortic insufficiency with a dedicated device. JACC: Case Reports. 2021;3(4):645–649. doi: 10.1016/j.jaccas.2021.01.021
   PubMedGoogle Scholar
• Rudolph TK, Baldus 9S. JenaValve–transfemoral technology. EuroIntervention. 2013 Sep 10;9(S):S101–2. doi: 10.4244/EIJV9SSA20
   PubMedGoogle Scholar
• Rodes-Cabau J, Williams MR, Wijeysundera HC, et al. Transcatheter aortic valve replacement with the HLT Meridian valve. Circ Cardiovasc Interv. 2019 Aug;12(8):e008053. doi: 10.1161/CIRCINTERVENTIONS.119.008053
   PubMed Web of Science ®Google Scholar
• (DIAC) Daic. HLT, Inc. Gains FDA approval for two TAVR clinical studies. DIAC; 2022 [24 Mar 2022]. Available from: https://www.dicardiology.com/content/hlt-inc-gains-fda-approval-two-tavr-clinical-studies
   Google Scholar
• Valve TA Introducing the Optimum TAV designed for durability.: thubrikar aortic valve; 2023 [updated May 2023; cited 2023 May 2023]. Available from: https://tavi.us/optimum-tav/
   Google Scholar
• Wiegerinck EM, Van Kesteren F, Van Mourik MS, et al. An up-to-date overview of the most recent transcatheter implantable aortic valve prostheses. Expert Rev Med Devices. 2016;13(1):31–45. doi: 10.1586/17434440.2016.1120665
   PubMed Web of Science ®Google Scholar
• Rezvova MA, Klyshnikov KY, Gritskevich AA, et al. Polymeric heart valves will displace mechanical and tissue heart valves: a new era for the Medical devices. Int J Mol Sci. 2023 Feb 16;24(4):3963. doi: 10.3390/ijms24043963
   PubMed Web of Science ®Google Scholar
• Onorati F, Biancari F, De Feo M, et al. Mid-term results of aortic valve surgery in redo scenarios in the current practice: results from the multicentre European RECORD (REdo cardiac operation research database) initiativedagger. Eur J Cardiothorac Surg. 2015 Feb;47(2):269–280. discussion 280. doi: 10.1093/ejcts/ezu116
   PubMed Web of Science ®Google Scholar
• Pibarot P, Ternacle J, Jaber WA, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J Am Coll Cardiol. 2020 Oct 20;76(16):1830–1843. doi: 10.1016/j.jacc.2020.08.049
   PubMed Web of Science ®Google Scholar
• Singh SK, Kachel M, Castillero E, et al. Polymeric prosthetic heart valves: a review of current technologies and future directions. Front Cardiovasc Med. 2023;10:10. doi: 10.3389/fcvm.2023.1137827
   Web of Science ®Google Scholar
• Yakubov SJ, Wittel J, Johnson G. Foldax® TRIA™ TAVI: a novel polymer transcatheter aortic valve: pilot chronic ovine model study. Cardiovasc Revascularization Med. 2022;40:95. doi: 10.1016/j.carrev.2022.06.215
   Google Scholar
• Rahmani B, Tzamtzis S, Sheridan R, et al. In vitro hydrodynamic assessment of a new transcatheter heart valve concept (the TRISKELE). J Cardiovasc Transl Res. 2017 Apr;10(2):104–115. doi: 10.1007/s12265-016-9722-0
   PubMed Web of Science ®Google Scholar